May 24 Webinar on “A Roadmap for Ending the COVID-19 Pandemic” (w/ J-E simultaneous interpretation)
May 12, 2022
COVID-19 continues to spread in countries around the world, but many governments are now rolling back social restrictions. How much longer will we need to live with the pandemic? Will a game changer emerge enabling a return to normalcy?
On May 24, the Tokyo Foundation for Policy Research will host a public webinar featuring Mitsuru Mukaigawara of Harvard University, who recently published an article in the journal Nature Medicine (https://www.nature.com/articles/s41591-022-01787-2.pdf) on an “equitable roadmap” for ending the pandemic, calling for a broad distribution of vaccines and therapeutics, responsive public health plans, and policies to protect the vulnerable.
Joining the discussion on possible ways to end the pandemic are Tokyo Foundation Research Director Keiichiro Kobayashi, a member of the government’s Subcommittee on Novel Coronavirus Disease Control; Research Director Kenji Shibuya, former professor and director of the Institute for Population Health at King’s College London; Senior Fellow Yasuharu Tokuda, director of the Muribushi Okinawa Center for Teaching Hospitals; Yik-Ying Teo, dean of the Saw Swee Hock School of Public Health at the National University of Singapore; and US infectious disease specialist Payal K. Patel, assistant professor at Michigan Medicine (University of Michigan). The panelists will bring diverse perspectives on the path to a COVID-free world, drawing on case studies from Japan, the United States, the United Kingdom, Singapore, and other countries.
After the presentation and panel discussion, there will be time for questions and answers, so please feel free to pose a question to the panelists. While questions can be asked through the chat feature, we also encourage you to send in questions in advance when registering.
Webinar on “A Roadmap for Ending the COVID-19 Pandemic”
Languages: Japanese and English (with simultaneous interpretation)
Date & Time: May 24, 2022 (Tuesday), 20:00 to 21:30
20:00 Presentation by Mitsuru Mukaigawara
20:30 Panel Discussion
The webinar is free and open to the public, but prior registration is required.
Mitsuru Mukaigawara, M.D., M.P.P., is an infectious disease physician and a Ph.D. candidate in government at Harvard University. Mukaigawara studies international relations, political methodology, and public policy, with a focus on the interaction between disease epidemics and international security. He received an M.D. from Tokyo Medical and Dental University, trained at Okinawa Chubu Hospital Internal Medicine Residency and Infectious Disease Fellowship, and then received an M.P.P. from Harvard Kennedy School. He is a recipient of the Graham T. Allison, Jr. Student Fellowship and the co-recipient of the Robert Belfer Annual Award for the best master's thesis in international relations at Harvard Kennedy School.
Keiichiro Kobayashi, Research Director, Tokyo Foundation for Policy Research, and Member of the Subcommittee on Novel Coronavirus Disease Control
Kenji Shibuya, Research Director, Tokyo Foundation for Policy Research, and former Professor, King's College London
Yasuharu Tokuda, Senior Fellow, Tokyo Foundation for Policy Research, and Director, Muribushi Okinawa Center for Teaching Hospitals
Yik-Ying Teo, Director and Dean of the Saw Swee Hock School of Public Health, National University of Singapore
Payal K. Patel, Assistant Professor, Michigan Medicine (University of Michigan)
The webinar is being hosted by the research program on “Developing Sustainable and Resilient Health, Nursing, and Long-Term Care Systems in the Post-COVID Era,” https://www.tkfd.or.jp/en/program/detail.php?u_id=33
Notes: The webinar will be livestreamed on Zoom. After registering, you will receive an auto reply email with the URL to join the webinar. All audio and video recordings, screenshots, downloads, and use of webinar materials without permission are prohibited. The webinar will be recorded, including Q&A, and later posted on the Tokyo Foundation website.
About this webinar: email@example.com
Media inquiries: firstname.lastname@example.org